Main > ONCOLOGY (**) > Lymphoma>HL>Classical>Stage 3/4>+ > TREAT.: > Co: USA. S. BrentuxiMAb Vedotin>+

---

Co: USA. S. BrentuxiMAb Vedotin>+'s subsections
(*) EU Approval Date: 2019. 02.11.
(*) JP Approval Date: 2018. 09.
(*) USA Approval Date: 2018. 03.
+CT AVD
>Previously Untreated
Company
Company Licensee EU; JP
Patents YES
TradeMark
TradeMark Web-Site

Co: USA. S. BrentuxiMAb Vedotin>+'s products
This section has no products